Sign In
Buy SDGR
$14.93
-0.0100 (-0.0669%)
At Close: Jun 03, 2026
Schrödinger Poised For Growth As FDA Shifts Away From Animal Testing (Upgrade)
10:26am, Saturday, 12'th Apr 2025
Schrödinger's stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug discovery platform. The company has strong collaborations with big pharma and a pr
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Tuesday, 18'th Mar 2025
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company's commo
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
08:30am, Monday, 10'th Mar 2025
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025.
Schrödinger: Still Waiting On A Catalyst
01:24am, Sunday, 02'nd Mar 2025
Schrödinger's Q4 2024 results and 2025 guidance were solid, yet the company's share price remains low due to ongoing losses. Cash burn is likely to moderate going forward, as investments in the compa
Schrödinger, Inc. (SDGR) Q4 2024 Earnings Call Transcript
07:27pm, Wednesday, 26'th Feb 2025
Schrödinger, Inc. (NASDAQ:SDGR ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Affairs Ramy F
Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates
07:00pm, Wednesday, 26'th Feb 2025
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.32 per share a year ago.
Schrödinger to Participate in Upcoming Investor Conferences
08:30am, Monday, 24'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 45th Annual Health Care Conference: Fireside cha
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26
08:30am, Wednesday, 12'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Schrödinger will report its fourth quarter and full-year 2024 financial results on Wednesday, February 26, 2025, after the financial markets close.
Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?
04:45am, Thursday, 23'rd Jan 2025
Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
07:00am, Monday, 13'th Jan 2025
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025. “We are very proud
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Tuesday, 17'th Dec 2024
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on December 12, 2024, the company granted restricted stock units (RSUs) with respect to 8,365 shares of the company's c
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
08:30am, Monday, 18'th Nov 2024
NEW YORK--(BUSINESS WIRE)--Schrödinger broadens and accelerates predictive toxicology initiative.
Schrodinger price target raised to $28 from $27 at Goldman Sachs
05:17pm, Wednesday, 13'th Nov 2024
Goldman Sachs raised the firm's price target on Schrodinger (SDGR) to $28 from $27 and keeps a Neutral rating on the shares. The company's Q3 results and announced deal with Novartis (NVS) involving b
Schrodinger price target raised to $28 from $27 at Goldman Sachs
05:17pm, Wednesday, 13'th Nov 2024
Goldman Sachs raised the firm's price target on Schrodinger (SDGR) to $28 from $27 and keeps a Neutral rating on the shares. The company's Q3 results and announced deal with Novartis (NVS) involving b
Schrödinger (SDGR) Q3 2024 Earnings Call Transcript
10:51am, Tuesday, 12'th Nov 2024
Schrödinger Inc. (NASDAQ:SDGR ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Ramy Farid - President, Chief Executive Officer Karen Akinsanya - President, R&D and
